The in vivo specificity study (Figure 7) showed that uptake of both [125I]I-Tyr-PEG2-RM26 and [111In]In-DOTA-PEG2-RM26 in tumours and GRPR-expressing tissues was specific. Here, GRPR is linked to neoplasm.